Improving patient outcomes by finally addressing an underlying cause of fibromyalgia and its related syndromes.
The lack of scientific understanding about an underlying root cause of fibromyalgia and its related syndromes—combined with the absence of appropriate diagnostic tools—has led to a “cocktail” treatment approach. Solely targeting symptom management rarely provides predictable, sustained relief.
The inability to solve the fibromyalgia puzzle often leads to suspicion that symptoms are a manifestation of the patient’s imagination—essentially adding insult to injury to the afflicted patient.
At Innovative Med Concepts, our aim is to lead the migration away from the current “symptom stopgap” treatment model and instead leverage our cutting-edge scientific discoveries to target the underlying pathophysiology of fibromyalgia and related conditions. We firmly believe Herpes Simplex Virus-1 (HSV-1) is a key contributor. Our combination anti-viral treatment is designed to change the paradigm by inhibiting replication and reactivation of the HSV-1 life cycle at different, critical stages—which, as CEO Dr. William Pridgen explains, “hits the virus in three different ways."